BCL2L1 and Miyoshi myopathy: Mechanistically, MEK inhibition raises BIM levels, whereas panobinostat dissociates BIM/MCL-1 and BIM/BCL-xL complexes in MM cells by acting as a MCL-1 and BCL-xL inhibitor.